| Association between sleep disordered breathing and aggressiveness markers of malignant cutaneous melanoma MÁ Martínez-García, A Martorell-Calatayud, E Nagore, I Valero, MJ Selma, ... European Respiratory Journal 43 (6), 1661-1668, 2014 | 111 | 2014 |
| Sleep-disordered breathing is independently associated with increased aggressiveness of cutaneous melanoma: a multicenter observational study in 443 patients MA Martinez-Garcia, F Campos-Rodriguez, E Nagore, A Martorell, ... Chest 154 (6), 1348-1358, 2018 | 65 | 2018 |
| First‐line treatment in lymphomatoid papulosis: a retrospective multicentre study R Fernández‐de‐Misa, B Hernández‐Machín, O Servitje, ... Clinical and Experimental Dermatology 43 (2), 137-143, 2018 | 35 | 2018 |
| Guselkumab: mid‐term effectiveness, drug survival, and safety in real clinical practice R Ruiz‐Villaverde, L Rodriguez‐Fernandez‐Freire, JC Armario‐Hita, ... Dermatologic Therapy 34 (2), e14798, 2021 | 31 | 2021 |
| Úlcera de Marjolin: carcinoma sobre cicatriz por quemadura I García-Morales, A Pérez-Gil, FM Camacho Actas Dermo-Sifiliográficas 97 (8), 529-532, 2006 | 30 | 2006 |
| A prospective multicenter cohort study of cutaneous melanoma: clinical staging and potential associations with HIF-1α and VEGF expressions MÁ Martínez-García, E Riveiro-Falkenbach, JL Rodríguez-Peralto, ... Melanoma Research 27 (6), 558-564, 2017 | 26 | 2017 |
| Guselkumab: Short‐term effectiveness and safety in real clinical practice. L Rodriguez Fernandez‐Freire, M Galán‐Gutierrez, JC Armario‐Hita, ... Dermatologic Therapy 33 (3), 2020 | 21 | 2020 |
| Intermittent hypoxia is associated with high hypoxia inducible factor-1α but not high vascular endothelial growth factor cell expression in tumors of cutaneous melanoma patients I Almendros, MÁ Martínez-García, F Campos-Rodríguez, ... Frontiers in neurology 9, 272, 2018 | 20 | 2018 |
| Interferon-induced cutaneous sarcoidosis in melanoma C Suárez-García, A Pérez-Gil, S Pereira-Gallardo, M Codes-Villena, ... Melanoma research 19 (6), 391-394, 2009 | 15 | 2009 |
| Angiosarcoma de cara y cuero cabelludo. A propósito de un caso B Repiso, A Pérez-Gil, O Argueta, JJ Ríos, I Sotillo, F Camacho Actas dermo-sifiliográficas (Ed. impresa) 90 (3), 104-108, 1999 | 11 | 1999 |
| Super responders to guselkumab treatment in moderate‐to‐severe psoriasis: a real clinical practice pilot series R Ruiz‐Villaverde, L Rodriguez‐Fernandez‐Freire, JC Armario‐Hita, ... International Journal of Dermatology 61 (8), 1029-1033, 2022 | 10 | 2022 |
| Marjolin's ulcer: burn scar carcinoma I García-Morales, A Pérez-Gil, FM Camacho Actas Dermo-sifiliograficas 97 (8), 529-532, 2006 | 10 | 2006 |
| Prognostic factors in patients with primary cutaneous anaplastic large cell lymphoma: a multicentric, retrospective analysis of the Spanish Group of Cutaneous Lymphoma R Fernández‐de‐Misa, B Hernández‐Machín, A Combalía, ... Journal of the European Academy of Dermatology and Venereology 34 (4), 762-768, 2020 | 9 | 2020 |
| Relationship between type 2 diabetes mellitus and markers of cutaneous melanoma aggressiveness: an observational multicentric study in 443 patients with melanoma E Nagore, MA Martinez‐Garcia, JD Gomez‐Olivas, E Manrique‐Silva, ... British Journal of Dermatology 185 (4), 756-763, 2021 | 8 | 2021 |
| Interstitial granulomatous dermatitis due to a rare myeloproliferative neoplasia S Cases-Merida, A Lorente-Lavirgen, A Pérez-Gil Indian Journal of Dermatology 63 (3), 264-267, 2018 | 8 | 2018 |
| Role of sleep apnea and long-term CPAP treatment in the prognosis of patients with melanoma: A Prospective Multicenter Study of 443 Patients JD Gómez-Olivas, F Campos-Rodriguez, E Nagore, A Martorell, ... Chest 164 (6), 1551-1559, 2023 | 7 | 2023 |
| Risankizumab: efficacy, safety, and survival in the mid-term (52 weeks) in real clinical practice in andalusia, spain, according to the therapeutic goals of the spanish … R Ruiz-Villaverde, L Rodriguez-Fernandez-Freire, A Pérez-Gil, ... Life 12 (11), 1883, 2022 | 7 | 2022 |
| Super-Responders in Moderate–Severe Psoriasis under Guselkumab Treatment: Myths, Realities and Future Perspectives R Ruiz-Villaverde, F Vasquez-Chinchay, L Rodriguez-Fernandez-Freire, ... Life 12 (9), 1412, 2022 | 6 | 2022 |
| Brentuximab vedotin in the treatment of cutaneous T‐cell lymphomas: Data from the Spanish Primary Cutaneous Lymphoma Registry C Muniesa, F Gallardo, I García‐Doval, MT Estrach, A Combalia, ... Journal of the European Academy of Dermatology and Venereology 37 (1), 57-64, 2023 | 5 | 2023 |
| Guselkumab as a switching strategy after anti‐TNFα, anti‐IL17, or anti‐IL12/23 therapies in moderate‐to‐severe psoriasis R Ruiz‐Villaverde, L Rodriguez‐Fernandez‐Freire, JC Armario‐Hita, ... Dermatologic Therapy 35 (10), e15760, 2022 | 5 | 2022 |
